Showing results (2151-2160 of 2,682) with videos related to
Sort By:
Pageof 269
Journal of Medicinal Chemistry|September 15, 1995
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.The Kaohsiung Journal of Medical Sciences|August 3, 2001
Surgical treatment for concomitant fractures of the femoral neck and diaphysis: a treatment protocolC H Chen, S H Hung, J C Chen, et al.Iscience|July 18, 2022
Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccinesPuthupparampil V Scaria, Chris G Rowe, Beth B Chen, et al.Lupus|August 24, 2018
Periorbital erythema and swelling as a presenting sign of lupus erythematosus in tertiary referral centers and literature reviewM Y Wu, C H Wang, C Y Ng, et al.Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|July 2, 2024
[A case of pleural metastasis of malignant peripheral nerve sheath tumor]M X Huang, P Tang, T T Cen, et al.Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|February 27, 2024
[Study of the effects of dietary patterns on glycemic control in community type 2 diabetic mellitus patients]L Y Lei, L Qin, Z G Wang, et al.Physical Review Letters|November 7, 2025
Observation of Giant Nernst Plateau in Ideal 1D Weyl PhaseY Zhang, J Q Cai, Peng-Lu Zhao, et al.Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindolesD S Dhanoa, S W Bagley, R S Chang, et al.Journal of Medicinal Chemistry|December 23, 1994
Triazolinone biphenylsulfonamides as angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.Journal of Medicinal Chemistry|August 19, 1994
Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinityW T Ashton, L L Chang, K L Flanagan, et al.Pageof 269